Quick Answer
Prestige Consumer Healthcare Inc. reported Cash and Equivalents of $97.88 million for fiscal year 2025.
Prestige Consumer Healthcare Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $97.88M | +110.6% |
| 2024 | $46.47M | -20.6% |
| 2023 | $58.49M | +115.2% |
| 2022 | $27.18M | -15.8% |
| 2021 | $32.30M | -65.9% |
| 2020 | $94.76M | +244.2% |
| 2019 | $27.53M | -15.4% |
| 2018 | $32.55M | -22.2% |
| 2017 | $41.85M | +53.7% |
| 2016 | $27.23M | +27.7% |
| 2015 | $21.32M | -24.8% |
| 2014 | $28.33M | +80.8% |
| 2013 | $15.67M | -17.6% |
| 2012 | $19.02M | +42.6% |
| 2011 | $13.33M | -67.6% |
| 2010 | $41.10M | +16.8% |
| 2009 | $35.18M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $62.37M | +22.6% | -47.6% |
| September 30, 2025 | $119.11M | +131.1% | -14.6% |
| June 30, 2025 | $139.50M | +307.2% | +42.5% |
| March 31, 2025 | $97.88M | +110.6% | +92.4% |
| December 31, 2024 | $50.87M | -20.0% | -1.3% |
| September 30, 2024 | $51.54M | -14.2% | +50.5% |
| June 30, 2024 | $34.26M | -37.2% | -26.3% |
| March 31, 2024 | $46.47M | -20.6% | -27.0% |
- Prestige Consumer Healthcare Inc. showed an increase of +110.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2009–2025 period, Prestige Consumer Healthcare Inc.’s cash and equivalents has grown by 178.2% (from $35.18 million to $97.88 million).
- The most recent figure is from Prestige Consumer Healthcare Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 9, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: